Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-1 receptors in the ovine placenta during the third trimester of pregnancy

Biology of Reproduction

Volumn 56, Issue 5, 1997, Pages 1189-1197

  Zheng, Jing ^a   Vagnoni, Karen E ^a   Bird, Ian M ^a   Magness, Ronald R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; MITOGENICITY; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SHEEP; THIRD TRIMESTER PREGNANCY; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALIA; OVIS; OVIS ARIES;

EID: 0030897137     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod56.5.1189     Document Type: Article

References (54)

1. Rudolph AM, Heymann MA. Circulatory changes during growth in the fetal lamb. Circ Res 1970; 26:289-299.
2. Reynolds LP, Redmer DA. Utero-placental vascular development and placental function. J Anim Sci 1995; 73:1839-1851.
3. Magness RR, Zheng J. Maternal cardiovascular alterations during pregnancy. In: Gluckman PD, Heymann MA (eds.), Pediatric and Perinatal Perspectives. The Scientific Basic. London: Edward Arnold Publishers; 1996: 762-772.
4. Makowski EL, Meschia G, Droegemueller W, Battaglia FC. Measurement of umbilical arterial blood flow to the sheep placenta and fetus in utero. Circ Res 1968; 23:623-631.
5. Stegeman JHJ. Placental development in the sheep and its relation to fetal development. Bijdragen Tot De Dierkunde (Contrib Zool) 1974; 44:3-72.
6. Brigstock DR. Growth factors in the uterus: steroidal regulation and biological actions. Clin Endocrinol Metab 1991; 5:791-808.
7. Reynolds LP, Killilea SD, Redmer DA. Angiogenesis in the female reproductive system. FASEB J 1992; 6:886-892.
8. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13:18-32.
9. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58:575-606.
10. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53:217-239.
11. D'Amore PA. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 1990; 9:227-238.
12. Hondermarck H, Courty J, Ledoux D, Blanckaert V, Barritault D, Boilly B. Evidence of high and low affinity binding sites for basic fibroblast growth factor in mouse placenta. Biochem Biophys Res Commun 1990; 169:272-281.
13. Rider V, Piva M, Cohen ME, Carlone DL. Alternative splicing and differential targeting of fibroblast growth factor receptor 1 in the pregnant rat uterus. Endocrinology 1995; 136:3137-3145.
14. Huckle WR, Earp HS. Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 1994; 5:177-194.
15. Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985; 105:141-145.
16. Le Nobel FAC, Hekking JWM, Van Straaten HWM, Slaaf DW, Struyker Boudier HAJ. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991; 195:305-306.
17. Le Nobel FAC, Schreurs NHJS, Van Straaten HWM, Slaaf DW, Smits JFM, Rogg H, Struijker-Boudier HAJ. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol 1993; 264:R460-R465.
18. Zheng J, Bird IM, Magness RR. Angiotensin II stimulates proliferation of ovine placental endothelial cells. J Soc Gynecol Invest 1996; 3(suppl):232A (abstract 348).
19. Mackanjee HR, Shaul PW, Magness RR, Rosenfeld CR. Angiotensin II vascular smooth muscle-receptors are not down-regulated in near-term pregnant sheep. Am J Obstet Gynecol 1991; 165:1641-1648.
20. Rosenfeld CR, Gresores A, Roy TA, Magness RR. Comparison of ANG II in fetal and pregnant sheep: metabolic clearance and vascular sensitivity. Am J Physiol 1995; 268:E237-E247.
21. Magness RR, Cox K, Rosenfeld CR, Gant NF. Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women. Am J Obstet Gynecol 1994; 171:668-679.
22. Cooke SF, Craven DJ, Symonds EM. A study of angiotensin II binding sites in human placenta, chorion, and amnion. Am J Obstet Gynecol 1985; 140:689-692.
23. Tence M, Petit A. Characterization of angiotensin binding sites in the human term placenta. Mol Cell Endocrinol 1989; 63:111-119.
24. Kurauchi O, Mizutani S, Nomura S, Kasugai M, Narita O, Tomoda Y. A comparison of the binding of angiotensin II to human placenta between normal and severe pre-eclamptic pregnancy. J Med 1990; 21: 209-216.
25. 2 receptors in the developing rat fetus. J Clin Invest 1991; 88:921-933.
26. Stirling D, Magness RR, Stone R, Waterman MR, Simpson ER. Angiotensin II inhibits luteinizing hormone-stimulated cholesterol side chain cleavage expression and stimulates basic fibroblast growth factor expression in bovine luteal cells in primary culture. J Biol Chem 1990; 265:5-8.
27. Reynolds LP, Millaway DS, Kirsh JD, Infeld JE, Redmer DA. Angiogenic activity of placental tissues of cows. J Reprod Fertil 1987; 81: 233-240.
28. Millaway DS, Redmer DA, Kirsch JD, Anthony RV, Reynolds LP. Angiogenic activity of maternal and fetal placental tissues of ewes throughout gestation. J Reprod Fertil 1989; 86:689-696.
29. Bird IM, Zheng J, Cale J, Magness RR. Pregnancy induces an increase in angiotensin II type-1 receptor expression in uterine but not systemic artery endothelium. Endocrinology 1997; 138:490-498.
30. Zheng J, Johnson ML, Redmer DA, Reynolds LP. Estrogen and progesterone receptors, cell proliferation, and c-fos expression in the ovine uterus during early pregnancy. Endocrinology 1996; 137:340-348.
31. Ku P, D'Amore PA. Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells. J Cell Biochem 1995; 58:328-343.
32. Grazul-Bilska AT, Redmer DA, Killilea SD, Kraft KC, Reynolds LP. Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle. Endocrinology 1992; 130:3625-3632.
33. Grazul-Bilska AT, Redmer DA, Killilea SD, Zheng J, Reynolds LP. Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle. Biochem Cell Biol 1993; 71: 270-277.
34. Brasaemle DL, Attie AD. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques 1988; 6: 418-419.
35. Viard L, Rainey WE, Capponi AM, Begeot M, Saez JM. Ovine adrenal fasciculata cells contain angiotensin-II receptors coupled to intracellular effectors but are resistant to the steroidogenic effects of this hormone. Endocrinology 1990; 127:2071-2078.
36. Bird IM, Mason JI, Rainey WE. Hormonal regulation of angiotensin II type 1 receptor expression and AT1-R mRNA levels in human adrenocortical cells. Endocr Res 1995; 21:169-182.
37. Cattini PA, Nickel B, Bock M, Kardami E. Immunolocalization of basic fibroblast growth factor (bFGF) in growing and growth-inhibited placental cells: a possible role for bFGF in placental cell development. Placenta 1991; 12:341-352.
38. Ferriani RA, Ahmed A, Sharkey A, Smith SK. Co-localization of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 1994; 10:259-268.
39. Shams M, Ahmed A. Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors 1994; 11:105-111.
40. Zheng J, Reynolds LP, Redmer DA, Magness RR. Immunolocalization of basic fibroblast growth factor (bFGF) and FGF receptor-1 (FGFR-1) in the ovine placenta during the third trimester of pregnancy. Biol Reprod 1996; 54 (suppl):128 (abstract 287).
41. Lapolt SP, Yamoto M, Yeljkovic M, Sincich C, Tor NY, Tsafriri A, Hsueh JA. Basic fibroblast growth factor induction of granulosa cell tissue type plasminogen activator expression and oocyte maturation: potential role as a paracrine ovarian hormone. Endocrinology 1990; 27:2357-2363.
42. Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 1987; 131:123-130.
43. Vagnoni KE, Zheng J, Magness RR. Placental gelatinase activity during the last third of gestation in sheep. J Anim Sci 1996; 74 (Suppl. 1):74. (Abstract 202).
44. Vagnoni KE, Zheng J, Mclntush EW, Magness RR. Tissue inhibitor of metalloproteinase-1 (TIMP-1) in the ovine placenta during the last third of gestation. Biol Reprod 1996; 54 (suppl):123 (abstract 266).
45. Irwin JC, Utian WH, Eckert RL. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. Endocrinology 1991; 129:2385-2392.
46. Zheng J. Studies of uterine growth during early pregnancy in ewes. Fargo, ND: North Dakota State University; 1995. Thesis.
47. Fricke PM, Jablonka A, Redmer DA. Fibroblast growth factors in the ovine follicle and effects on proliferation of the thecal cells. J Reprod Fertil 1992; Abst Ser 9:62.
48. Magness RR, Rosenfeld CR, Faucher DJ, Mitchell MD. Uterine prostaglandin production in ovine pregnancy: effects of angiotensin II and indomethacin. Am J Physiol 1992; 263:H188-H197.
49. Kingdom JP, McQueen J, Connell MC, Whittle MJ. Fetal angiotensin II levels and vascular (type I) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1993; 100:476-482.
50. Petit A, Geoffroy P, Belisle S. Expression of angiotensin II type-I receptor and phospholipase C-linked Gαq/II protein in the human placenta. J Soc Gynecol Invest 1996; 3:316-321.
51. Normal J, Badie-Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A. EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 1987; 253:F299-F309.
52. Guo D, Inagami T. Epidermal growth factor-enhanced human angiotensin II type 1 receptor. Hypertension 1994; 23:1032-1035.
53. Langlois D, Ouali R, Berthelon MC, Derrien A, Saez JM. Regulation by growth factors of angiotensin II type-1 receptor and the α subunit of GQ and G11 in bovine adrenal cells. Endocrinology 1994; 135: 480-483.
54. Nickening G, Murphy TJ. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol Pharmacol 1994; 46:653-659.